The company’s management will webcast a corresponding conference call beginning at
About
With its corporate headquarters in
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
Source:
2023 GlobeNewswire, Inc., source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.71 USD | -0.73% | -1.81% | -9.36% |
30/04 | Transcript : Nautilus Biotechnology, Inc., Q1 2024 Earnings Call, Apr 30, 2024 | |
30/04 | Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
The company’s management will webcast a corresponding conference call beginning at
About
With its corporate headquarters in
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
Source:
2023 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-9.36% | 34Cr | |
+29.78% | 4.82TCr | |
-0.75% | 4.17TCr | |
+44.02% | 4.1TCr | |
-5.31% | 2.88TCr | |
+10.47% | 2.56TCr | |
-22.49% | 1.9TCr | |
+9.06% | 1.29TCr | |
+28.64% | 1.2TCr | |
-2.42% | 1.18TCr |